Skip to main content

Month: May 2020

Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery

CAMBRIDGE, Mass., May 18, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has appointed Kenneth Rhodes, PhD, as Senior Vice President, Therapeutics Discovery. In this newly created position, Dr. Rhodes will be responsible for defining the strategy and guiding discovery research to design new therapeutic candidates and advance them to the clinic, with an initial focus on neurological diseases.“Ken is joining Wave at an exciting time for the company, when we are making chemistry advancements and developing new modalities with our PRISM platform that have the potential to expand our pipeline with innovative stereopure oligonucleotides to treat intractable neurological...

Continue reading

Todos Medical Announces First Commercial Sale of COVID-19 Antibody Tests

 Sub-distributor has network of state and local government clients seeking testing solutions Return to Church program being initiated in Orlando, Fla. areaREHOVOT, Israel, SINGAPORE and NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on the distribution of a comprehensive suite of solutions for the screening and diagnosis of COVID-19 and the development of blood tests for the early detection of cancer and Alzheimer’s disease, today announced its first commercial sale of COVID-19 tests.  The sale was made via a sub-distribution agreement with a U.S.-based medical distribution company with clients in state and local governments throughout the Southeastern United States who are seeking comprehensive testing solutions for Return-to-Work programs....

Continue reading

Comment to Sixth Street Partners and Lintgen Adjacent Investments S.à r.l press release concerning the restructuring of T1 Mall of Tallinn

AS Pro Kapital Grupp has notified about the initiation of reorganization proceedings of its subsidiary AS Tallinna Moekombinaat by the ruling of the Harju County Court issued on 3 April 2020. On 7 May 2020 AS Tallinna Moekombinaat presented the reorganization plan to the creditors for review and formation of position. The majority of the creditors have already voted in favor of the reorganization plan.On 18th of May 2020 TPG Sixth Street Partners and Lintgen Adjacent Investments S.à r.l (hereinafter TPG Sixth Street Partners) issued a press release stating they will vote against the restructuring plan of AS Tallinna Moekombinaat and called other creditors to also vote against the plan.TPG Sixth Street Partners has not been acting in good faith towards AS Tallinna Moekombinaat and its creditors, tenants and collaboration parties.By making...

Continue reading

Kommentaar Sixth Street Partnerite ja Lintgen Adjacent Investments S.à r.l pressiteatele T1 Mall of Tallinn restruktureerimise kohta

AS Pro Kapital Grupp on teavitanud tütarettevõtte AS-i Tallinna Moekombinaat suhtes saneerimismenetluse algatamisest 03. aprilli 2020 Harju Maakohtu määrusega. 7. mail 2020 esitas AS Tallinna Moekombinaat saneerimiskava võlausaldajatele tutvumiseks ning seisukoha edastamiseks. Enamus võlausaldajatest on juba hääletanud saneerimiskava poolt.TPG Sixth Street Partners ja Lintgen Adjacent Investments S.à r.l (edaspidi TPG Sixth Street Partners) avaldasid 18. mail 2020 pressiteate, milles teatasid, et hääletavad AS-i Tallinna Moekombinaat saneerimiskava vastu ning kutsusid üles ka teisi võlausaldajaid kava vastu hääletama.TPG Sixth Street Partners ei ole käitunud heas usus AS-i Tallinna Moekombinaat ning ettevõtte võlausaldajate, üürnike ja koostööpartnerite suhtes.Eksitavast avalikust pressiteatest on selgunud, et TPG Sixth Street Partnersi...

Continue reading

Comment to Sixth Street Partners and Lintgen Adjacent Investments S.à r.l press release concerning the restructuring of T1 Mall of Tallinn

AS Pro Kapital Grupp has notified about the initiation of reorganization proceedings of its subsidiary AS Tallinna Moekombinaat by the ruling of the Harju County Court issued on 3 April 2020. On 7 May 2020 AS Tallinna Moekombinaat presented the reorganization plan to the creditors for review and formation of position. The majority of the creditors have already voted in favor of the reorganization plan.On 18th of May 2020 TPG Sixth Street Partners and Lintgen Adjacent Investments S.à r.l (hereinafter TPG Sixth Street Partners) issued a press release stating they will vote against the restructuring plan of AS Tallinna Moekombinaat and called other creditors to also vote against the plan.TPG Sixth Street Partners has not been acting in good faith towards AS Tallinna Moekombinaat and its creditors, tenants and collaboration parties.By making...

Continue reading

Kraig Biocraft Laboratories Holds First Meeting of Board of Directors Elect

ANN ARBOR, Mich., May 18, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”) announces that the Company’s Board of Directors held its first meeting with its four new members-elect in attendance.  During this meeting, management briefed the board on the Company’s plans for 2020 expansion and growth.  The scheduled increases in spider silk production for 2020 and the role of the new “knock-in/knock-out” technology were also discussed.The Company’s expansion of its Board of Directors is intended to strengthen its corporate governance and to directly address the requirements for listing on a national exchange. The new members-elect are expected to be formally nominated and seated as voting members within the next sixty days. The expanded board brings a wealth of experience in international manufacturing...

Continue reading

Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress

Total Revenues were $33.3 Million, an Increase of 24% Year-over-YearNet Income was $5.2 Million, an Increase of 6% Year-over-YearCompany Reports Continued Progress of its Development Program of a Plasma-Derived Hyperimmune IgG Therapy for COVID-19; Product Availability for Clinical and Compassionate Use Treatment for COVID-19 patients in Israel is Expected by End of the Second Quarter of 2020Company’s Manufacturing Plant Continues to Operate Without Significant Disruption During Ongoing Coronavirus (COVID-19) OutbreakKamada Reiterates Full-Year 2020 Total Revenue Guidance of $132 Million to $137 MillionREHOVOT, Israel, May 18, 2020 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced financial results for the three months ended March 31, 2020.“As the ongoing COVID-19...

Continue reading

Verizon officially closes BlueJeans deal

What you need to know:Verizon acquired BlueJeans Network, Inc. on May 15NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — Verizon welcomes 390 new employees today after officially closing the deal with BlueJeans Network, Inc. on May 15.  Keeping businesses connected has always been a priority for Verizon. Adding BlueJeans to Verizon’s Advanced Communications portfolio is critical now more than ever to keep businesses, from small organizations to some of the world’s largest multinational brands, operating at the highest level.BlueJeans products complement Verizon’s mobile-first business solutions, like One Talk, and will be deeply integrated into Verizon’s current and future 5G product roadmap.Regularly cited as a market-leading video conferencing and collaboration tool, BlueJeans enables cloud-based meetings and large, interactive...

Continue reading

Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*

Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged ProstateWAYNE, Pa., May 18, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced that data from two analyses of the UroLift® System were presented at the American Urological Association (AUA) 2020 Virtual Science event. This new multimedia reinvention of the AUA 2020 poster and podium sessions was designed to connect and educate participants who are unable to gather as a result of the COVID-19 pandemic. Results from the analyses highlight the effectiveness of the minimally invasive treatment for benign prostatic hyperplasia (BPH) in preserving sexual function* and in a real-world setting.“The UroLift System is an...

Continue reading

So-Young Reports First Quarter 2020 Unaudited Financial Results

BEIJING, May 18, 2020 (GLOBE NEWSWIRE) — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the three months ended March 31, 2020. First Quarter 2020 Financial HighlightsTotal revenues were RMB182.6 million (US$25.8 million1), exceeding the high-end of the Company’s previous guidance of RMB160 million to RMB180 million.Net loss was RMB35.9 million (US$5.1 million), compared with a net income of RMB45.9 million in the same period of 2019.Non-GAAP net loss2 was RMB21.6 million (US$3.1 million), compared with a non-GAAP net income of RMB51.9 million in the same period of 2019.First Quarter 2020 Operational HighlightsAverage...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.